Cost Eff Bariatric Surgery Webinar-Dr Reno

Download as pdf or txt
Download as pdf or txt
You are on page 1of 30

Cost Effectiveness of

Bariatric Surgery
Reno Rudiman

Perhimpunan Dokter Spesialis Bedah Digestif Indonesia


Introduction

Bariatric surgery is a well-documented treatment for


obesity

But uncertainties about the degree to which such surgery


is associated with health care cost reductions that are
sustained over time.

Background

In 2008, approximately 1.4 billion adults were considered


overweight worldwide

Of the 1.4 billion adults, approximately 300 million women


and > 200 million men were estimated to be obese.

Twelve million adults in the USA are considered morbidly


obese with body mass index (BMI) ≥ 40 kg/m2

Obesity in Indonesia

Riset Kesehatan Dasar (Riskedas) 2018:


Obesity prevalence in age over 18 is 21.8%

North Sulawesi 30.2%

DKI Jakarta 29.8%

East Kalimantan 28.7%

A signi cant increase from 2007 (10.7%) & 2013 (11.5%)


fi

Obesity Associated Problems

Obesity is associated with several comorbidities that increase


mortality rates

It is associated with hypertension, coronary artery disease,


dyslipidemia, metabolic liver disease, renal and urological
diseases, sleep apnea, diabetes, osteoarthritis, psychiatric
comorbidity, gastroesophageal re ux disease (GERD), and
various cancers

fl
Bariatric Surgery

Behavioral therapy, diet, and weight reduction medications have been


shown to be ineffective on morbidly obese patients

Since 2003, the use of surgery to treat morbid obesity has increased

Bariatric surgery is considered as a treatment option for class III (BMI


≥ 40 kg/m2) or class II (BMI 35.0–39.9 kg/m2) obesity with obesity-
related comorbidities that have previously not been successfully
treated with non-surgical interventions

The long-term effect of bariatric surgery was proven to be successful


with mean excess weight loss beyond 60%, but the short and long-
term surgical complication rate is relatively large

Three most common Bariatric Surgeries

LAGB: reversibility, simple but less effective

LRYGB: gold standard, high level of ef cacy

LSG: newer technique, easier to perform


fi

Ef cacy Outcomes
for Weight Reduction
fi

Ef cacy for Improvement in


Diabetes-Related Outcomes
fi

In summary, in addition to the effective weight loss


achieved by patients undergoing bariatric surgical
procedures, a substantial majority of patients with
diabetes, hyperlipidemia, hypertension, and obstructive
sleep apnea experienced complete resolution or
improvement of their comorbid condition

JAMA, October 13, 2004—Vol 292, No. 14


JAMA Surg. 2013;148(6):555-562. Published online February 20, 2013. doi:10.1001/jamasurg.2013.1504


During a 6-year follow-up period of this privately insured


cohort, unable to identify any short- or long-term
reductions in overall health care costs associated with
surgery.

Suggests that to assess the value of bariatric surgery,


future studies should focus on the potential bene t of
improved health and well-being of persons undergoing the
procedure rather than on cost savings

JAMA Surg. 2013;148(6):555-562. Published online February 20, 2013. doi:10.1001/jamasurg.2013.1504


fi

Obesity Surgery. https://doi.org/10.1007/s11695-018-3525-0. Published online: 6 October 2018

In summary, RYGB, LAGB and BPD/DS lead to substantial


weight loss which continues for at least 10 years

Long-term data on sleeve gastrectomy are modest at this


time

Guidance to the obese patient should balance durable


effectiveness with risks, costs, health bene ts and effect
on quality of life

Obesity Surgery. https://doi.org/10.1007/s11695-018-3525-0. Published online: 6 October 2018

fi

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.

In summary, LSG has morbidity and effectiveness


positioned between the LAGB and the LRYGB/ORYGB for
data up to one year

As obesity is a lifelong disease, longer term comparative


effectiveness data are most critical, and are yet to be
determined

Hutter et al. Ann Surg. 2011 September ; 254(3): 410–422. doi:10.1097/SLA.0b013e31822c9dac.


Obesity Surgery https://doi.org/10.1007/s11695-017-3100-0. Published online: 15 January 2018


Obesity Surgery https://doi.org/10.1007/s11695-017-3100-0. Published online: 15 January 2018


LRYGB is the optimal bariatric technique, being the most


cost-effective compared to LSG, LAGB, and no surgery

However, LSG was the most cost-effective choice when


initial BMI ranged between 35 and 39.9 kg/m2

Obesity Surgery https://doi.org/10.1007/s11695-017-3100-0. Published online: 15 January 2018


Thank You
@rudimansurgery

You might also like